Home monitoring device aims to cut COPD hospitalizations by catching flare-ups early
NCT ID NCT07697105
First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time
Summary
This trial tests whether a telemonitoring device called HCAlert can reduce hospitalizations and emergency visits for people with chronic obstructive pulmonary disease (COPD). Participants use the device at home to regularly measure their health, allowing doctors to spot worsening symptoms early. The study includes 340 adults with COPD who have had at least one flare-up in the past year. If successful, this approach could help patients manage their condition at home and avoid urgent care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HCAlert medical telemonitoring device
- What this could lead to
- If effective, this telemonitoring program could help COPD patients avoid hospitalizations and emergency visits by detecting worsening symptoms early.
- What could go wrong
- This is a single study with 340 participants, and results may not apply to all COPD patients. The device requires daily use, which some may find burdensome.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BPCO are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.